SciPio Bioscience

Scipio bioscience develops a new generation of sample preparation solution for single-cell studies, in the form of user-friendly and cost-effective benchtop kits, for use in sequencing applications in clinical and basic research, with an initial focus on transcriptomics. Scipio Bioscience has developed the protocol from the initial proof-of-concept studies to a prototype kit ready for beta-testing in collaboration with several research teams. The company, founded in 2017, is hosted in the iPEPS-ICM incubator of the Brain & Spine Institute (ICM, Pitié-Salpêtrière Hospital, Paris).

Team Members
more about
Cheryl Zimberlin
Investment Director
more about
Anique ter Braake
Latest News Entry
Scipio bioscience selected for €2.5M European Innovation Council grant

Scipio bioscience has been selected by the @European Innovation Council for a €2.5M grant to pursue their efforts toward the next generation of single-cell tools

Scipio bioscience launches commercialization in Europe of Asteria, its RNA sequencing kit

Scipio bioscience announces the launch in Europe of Asteria©, its innovative kit for sequencing RNA on individual cells on lab benchtops

Scipio bioscience raises €6.0 M Series A financing

To develop and launch a kit dedicated to sample preparation for single-cell RNAsequencing

all portfolio news